Health ❯ Healthcare ❯ Neurology

Dementia

Alzheimer's Disease Risk Factors Frontotemporal Dementia Cognitive Decline Lewy Body Dementia Cognitive Impairment Mild Cognitive Impairment Cognitive Training Vascular Dementia Dementia Prevention Alzheimer's Research Treatment Options Alzheimer's Treatments Dr. Iris Trender-Gerhard Molecular Markers Amyloid Protein Diagnosis Biomarkers Clinical Dementia Rating Alzheimer's Disease Treatments Research Studies Tau Proteins Cognitive Dysfunction Biobanks Amyloid Detection Care Approaches Prevalence Misdiagnosis Treatment Dementia Risk Frontotemporal Lobar Degeneration Alzheimer's Symptoms Amyloid Plaques

FDA Approves Auvelity as First Non‑Antipsychotic for Alzheimer’s Agitation

The approval reflects strong relapse‑prevention data from ACCORD‑2 over mixed acute results.

NIH Awards $15.85 Million to UC Davis and UC San Diego for Long-Term Latino Brain Aging Study

Severe Infections Tied to Higher Dementia Risk in Large Finnish Study

Blood Studies Point to Complementary Alzheimer’s Biomarkers for Prediction and Staging

Genetic Study Links Obesity and High Blood Pressure to Causal Risk of Vascular Dementia

Shingles Vaccine Linked to Lower Dementia Risk in New Analyses

Shingles Vaccine Linked to Lower Dementia Risk and Fewer Deaths in New Analysis

Shingles Vaccine Linked to Slower Dementia Progression and Lower Risk, Welsh Studies Find

Wendy Williams Returns to NYFW With Rare Back-to-Back Appearances

Hearing Aids Started in the 60s Linked to 61% Lower Dementia Risk, JAMA Neurology Study Finds

GLP-1 Agonists Cut Dementia and Mortality Risk Versus Metformin in Type 2 Diabetes

Insulin Resistance Blood Test Forecasts Rapid Alzheimer’s Decline

FDA Approves First Blood Test for Alzheimer’s Diagnosis